• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2400549 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2024-10-15 Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH view
CYHS2101683 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Generic Drug 2021-09-06 Jiangsu Hansoh Pharmaceutical Group Co Ltd view
CYHB2102105 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2021-11-04 CSPC-NBP Pharmaceutical Co Ltd view
CYHS2201530 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Generic Drug 2022-09-15 Jiangsu Vanguard Pharmaceutical Co Ltd view
CYHB2300165 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2023-01-30 Sichuan Kelun Pharmaceutical Co Ltd view
CYHB2500383 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2025-02-25 Humanwell Puracap Pharmaceuticals (Wuhan) Co Ltd view
CYHB2400592 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2024-05-07 CSPC-NBP Pharmaceutical Co Ltd view
JYHZ2100749 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(5.1) License Renew 2021-12-31 Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH view
CYHB2401419 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2024-09-11 Humanwell Puracap Pharmaceuticals (Wuhan) Co Ltd view
CYHB2300164 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2023-01-30 Sichuan Kelun Pharmaceutical Co Ltd view
CYHB2500384 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2025-02-25 Humanwell Puracap Pharmaceuticals (Wuhan) Co Ltd view
CYHS2101684 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Generic Drug 2021-09-06 Jiangsu Hansoh Pharmaceutical Group Co Ltd view
CYHB2400591 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2024-05-07 CSPC-NBP Pharmaceutical Co Ltd view
CYHS2501693 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Generic Drug 2025-05-10 Kunming Jida Pharmaceutical Co Ltd view
CYHS2201529 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Generic Drug 2022-09-15 Jiangsu Vanguard Pharmaceutical Co Ltd view
JYHB2200572 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2022-10-25 Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH view
CYHB2401418 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Supplementary Application 2024-09-11 Humanwell Puracap Pharmaceuticals (Wuhan) Co Ltd view
CYHS2102198 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(4) Generic Drug 2021-12-17 Sichuan Kelun Pharmacy Institute Co Ltd;Sichuan Kelun Pharmaceutical Co Ltd view
JYHS2500008 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(5.2) Import Drug Application 2025-02-19 Cipla (China) Pharmaceutical Co Ltd;Cipla Ltd view
JYHZ2100750 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(5.1) License Renew 2021-12-31 Boehringer Ingelheim International GmbH;Catalent Germany Eberbach GmbH view